• Home
  • News
2022-01-04 | views:986
Which Antibodies Can Neutralize Omicron?
2021-12-31 | views:690
"역량 총동원"…政 '글로벌 백신 허브’ 천명
2021-12-27 | views:1549
Scientists Taking Lessons From mRNA Technology Used For COVID Vaccines
2021-12-24 | views:1322
mRNA Will Do More than Conquer COVID
2021-12-21 | views:1022
차세대 혁신 신약 개발, mRNA 이어 마이크로 RNA 뜬다
2021-12-15 | views:1316
“폐암 NGS 패널 검사, 기적을 만드는 도구입니다
2021-12-10 | views:1429
Bringing NGS-Based Testing Closer to Home: The Need for Wider Access
2021-12-07 | views:2029
The Omicron Variant Highlights the Need for Smarter, Future-Proof Vaccine Design
2021-12-07 | views:1823
Study analyzes the contribution of AI to cancer patient care and vaccine design
  1.   
  2. 33
  3. 34
  4. 35
  5. 36
  6. 37
  7. 38
  8. 39
  9.   
  • 서울시 금천구 디지털로 173, 10층 (가산동, 엘리시아)
  • 대표 번호 : 02-890-8700
  • 주주 문의 : 02-6964-8770
  • Fax : 02-6964-8755

About Us

Goals & Promise

Leadership

Company History

IR

Notice & IR

Disclosure Information

Dx&Vx 2023 Award Impact

Contact

개인정보 처리방침 사용자 이용약관 twitter icon @dxvx_official
© 2024 Dx&Vx. All Rights Reserved.